Recent

% | $
Quotes you view appear here for quick access.

Response Genetics, Inc Message Board

  • frankfrazzano frankfrazzano Oct 8, 2012 8:21 AM Flag

    Response Genetics Regains Compliance with NASDAQ Listing Standards

    Response Genetics has added a news release to its Investor Relations website.
    Title: Response Genetics Regains Compliance with NASDAQ Listing Standards

    Date(s): 8-Oct-2012 8:01 AM

    For a complete listing of our news releases, please click here

    LOS ANGELES , Oct. 8, 2012 /PRNewswire/ -- Response Genetics, Inc. (Nasdaq: RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, announced today that on October 5, 2012 , the Company was notified that it has regained compliance with the NASDAQ Capital Market and its minimum market value of listed securities requirement. The Company regained compliance with NASDAQ Marketplace Rule 5550(b)(2) and was notified by NASDAQ that the delisting matter is now closed.

 
RGDX
0.31-0.03(-8.53%)Apr 20 4:00 PMEDT